Bellevue Group AG Lowers Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bellevue Group AG lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 464,377 shares of the medical equipment provider's stock after selling 32,398 shares during the quarter. Intuitive Surgical accounts for 4.7% of Bellevue Group AG's investment portfolio, making the stock its 4th largest holding. Bellevue Group AG owned 0.13% of Intuitive Surgical worth $242,386,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in ISRG. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $82,517,000. Sycomore Asset Management increased its holdings in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after buying an additional 4,079 shares during the last quarter. China Universal Asset Management Co. Ltd. raised its holdings in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock valued at $5,138,000 after buying an additional 525 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in shares of Intuitive Surgical by 73.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider's stock worth $132,657,000 after purchasing an additional 114,149 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This represents a 7.58 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director now directly owns 6,371 shares in the company, valued at $3,312,920. This trade represents a 27.36 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,313 shares of company stock worth $17,229,143. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Stock Up 1.1 %

Shares of ISRG traded up $5.69 during mid-day trading on Wednesday, hitting $536.15. 1,311,349 shares of the company's stock were exchanged, compared to its average volume of 1,626,933. The stock has a market cap of $192.17 billion, a price-to-earnings ratio of 83.64, a P/E/G ratio of 5.85 and a beta of 1.70. The firm has a fifty day moving average of $502.67 and a two-hundred day moving average of $534.43. Intuitive Surgical, Inc. has a twelve month low of $379.67 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the company earned $1.50 earnings per share. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on ISRG shares. JPMorgan Chase & Co. lifted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price objective on the stock. UBS Group raised their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Finally, Citigroup boosted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.